Infineon Technologies has launched MOTIX TLE9189 gate driver IC, specifically designed for safety-critical applications.

--(BUSINESS WIRE)--Viridian Therapeutics ... a pivotal program for veligrotug (VRDN-001), including two global phase 3 clinical trials (THRIVE and THRIVE-2), to evaluate its efficacy and safety ...

Toshiba Starts Sample Shipments of Gate Driver IC for Three-Phase Brushless DC Motors in Diverse Automotive Applications ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced new phase III data from the ... in the phase III READY-1, -2 and -3 clinical trials. 1,4,9,11 TEAEs were all mild to moderate, reported ...

VANCOUVER, British Columbia — Canadian life sciences company Ondine Biomedical announces that it is accelerating its final preparations for a Q4 2024 start to its key pivotal US Phase 3 trial ... of ...

VANCOUVER, British Columbia — Canadian life sciences company Ondine Biomedical announces that it is accelerating its final preparations for a Q4 2024 start to its key pivotal US Phase 3 trial ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...

Canadian life sciences company Ondine Biomedical announces that it is accelerating its final preparations for a Q4 2024 start to its key pivotal US Phase 3 ... Cdn $5.5 (US$4 m,£3.1 m).

The French debutant looks sure to advance to the knockout phase starting in February. Atalanta won 2-0 at Stuttgart to stay ...

Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported ...